We have attached herewith copy of newspaper publication. Kindly take the same on your record. Thank you.

October 31, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Compliance pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, With reference to the above subject, please find attached herewith copy of Newspaper Advertisement dated October 31, 2026 in Financial Express (English edition) and in Financial Express (Gujarati edition) for publication of copy of extract of Financial Results for the Quarter and Half Year Ended September 30, 2026. Kindly take the same on record. Thanking You. Yours Faithfully, For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 Encl: As above ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in (cid:149)_¬hm™ ¬¼(cid:149)‡¼¼û¼ÆZ : A-77, _.@¼¼A.mÂ.¬¼Â. ¬¼¼¡¼ÿ¼Â (û¼Z]Ƭ¼(cid:149)), ½]Ÿ¼¼Ì-¡¼m¼Ìy(cid:149)¼-391776, ö¼Ì‡¼ : +91 8487878075 ¡¼Ìù¼¬¼¼Ah : www.ratnaveer.com, Aû¼ÌAÿ¼ : cs@ratnaveer.com, CIN : L27108GJ2002PLC040488 ½¡¼S¼t¼¼Ì ¬¼ŠhÌûù¼(cid:149) 2026 ¬¼ŠhÌûù¼(cid:149) 2025 ¬¼ŠhÌûù¼(cid:149) 2026 ¬¼ŠhÌûù¼(cid:149) 2025 ¬¼ŠhÌûù¼(cid:149) 2025 ¬¼ŠhÌûù¼(cid:149) 2025 ¬x¼º¼: ¡¼m¼Ìy(cid:149)¼ û¼Ì‡¼Ì½]ZS¼ m¼ü¼(cid:149)ÌLh(cid:149) t¼¼(cid:149)ÂQ¼: 30.10.2026 (mÂ@¼¼A@¼Ì‡¼ 00495922) MIDLAND MICROFIN LIMITED Registered Office:- The AXIS, Plot No.1, R.B. Badri Dass Colony, G.T Road, Jalandhar PB 144001 (INDIA) (CIN: U65921PB1988PLC008430) Tel : +91-181-5076000, Fax No : +91- 181-2236070 Website : www.midlandmicrofin.com Extract of the Unaudited Financial Results for the quarter and half year ended September, 30, 2026(Rupees in millions unless otherwise stated) Quarter Ended Half year ended Year Ended Particulars 30-09-2026 30-06-2026 30-09-2025 30-09-2026 30-09-2025 31-03-2026 No. Unaudited Unaudited Unaudited Unaudited Unaudited Audited 1 Total Income from Operations 1,802.38 1,865.57 1,640.38 3,667.95 3,104.92 6,369.57 2 Net Profit / (Loss) for the period (before Tax, 179.24 131.50 63.26 310.74 110.05 417.81 Exceptional and/or Extraordinary items) 3 Net Profit / (Loss) for the period before tax (after 179.24 131.50 63.26 310.74 110.05 417.81 Exceptional and/or Extraordinary items) 4 Net Profit / (Loss) for the period after tax (after 138.61 102.24 51.41 240.85 90.75 347.64 Exceptional and/or Extraordinary items) 5 Total Comprehensive Income for the period [Comprising Profit / (Loss) for the period (after tax) and Other 121.13 100.31 5.38 221.44 62.76 401.83 Comprehensive Income (after tax)] 6 Paid up Equity Share Capital 523.87 523.87 523.73 523.87 523.73 523.73 7 Instruments entirely equity in nature 472.18 472.18 465.86 472.18 465.86 472.12 8 Reserves (excluding Revaluation Reserve) 2,559.42 2,438 .08 2,078.36 2,559.42 2,078.36 2,338.54 9 Securities Premium Account 3,494.56 3,494 .56 3,398.67 3,494.56 3,398.67 3,492.58 10 Net worth 7,050.03 6,928.69 6,466.62 7,050.03 6,466.62 6,826.97 11 Paid up Debt Capital / Outstanding Debt 28,317.40 29,179 .61 22,948.48 28,317.40 22,948.48 27,394.35 12 Outstanding redeemable preference shares 282.39 275.04 254.32 282.39 254.32 267.95 13 Debt Equity Ratio (in times) 3.94 4.14 3.55 3.94 3.55 4.01 14 Earnings Per Share (of Rs.10/- each) (for continuing and discontinued operations) - 1. Basic (Rs.) 2.65 1.95 0.98 4.60 1.73 6.64 2. Diluted (Rs.) 2.28 1.68 0.86 3.96 1.52 5.79 15 Capital Redemption Reserve 106.20 106.20 106.20 106.20 106.20 106.20 16 Debenture Redemption Reserve 36.63 36.63 36.63 36.63 36.63 36.63 17 Debt Service Coverage Ratio Not Applicable Not Applic able Not Applicable Not Applicable Not Applicable Not Applicable 18 Interest Service Coverage Ratio Not Applicable Not Applic able Not Applicable Not Applicable Not Applicable Not Applicable Notes: 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on October 29, 2026, in accordance with the requirements of Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The above results for the quarter and half year ended September 30, 2026 have been reviewed by the Statutory Auditors of the Company.. 2. The above is an extract of the detailed format of Unaudited Financial Results filed with the Stock Exchange under Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of Unaudited Financial Results are available on the stock exchange website (www.bseindia.com) and the website of the Company (www.midlandmicrofin.com). 3. The above Financial Results have been prepared in accordance with Indian Accounting Standards (Ind-AS) notified by the Ministry of Corporate Affairs. For Midland Microfin Limited Place : Jalandhar Sd/- Date: October 29, 2026 Amardeep Singh Samra, Managing Director ANLON HEALTHCARE LIMITED CIN:L24230GJ2013PLC077543(cid:149)RegisteredOfce:101/102,SilverCoinComplex,Opp.CrystalMall,KalawadRoad, Rajkot-360005.Gujarat(India)(cid:149)PhoneNo.+917069690081/82(cid:149)Email:info@anlonhealthcare.com(cid:149)www.anlon.in EXTRACTSOFSTANDALONEANDCONSOLIDATEDUNAUDITEDFINANCIALRESULTSFORTHEQUARTERANDHALFYEARENDEDSEPTEMBER30,2026 (Rs.InLakhsExceptPerShareData) Standalone Consolidated 3Months 3Months 3Months HalfYear HalfYear Year 3Months 3Months 3Months HalfYear HalfYear Year Particulars ended ended ended ended ended ended ended ended ended ended ended ended 30/09/2026 30/06/2026 30/09/202530/09/202630/09/202531/03/202630/09/2026 30/06/2026 30/09/202530/09/202630/09/202531/03/2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Unaudited Unaudited Unaudited Unaudited Unaudited Audited TotalIncomefromOperation 1 (net) 6045.46 3097.56 5220.13 9143.02 8549.85 17649.87 10560.97 8756.27 5220.13 19317.24 8549.85 19190.70 NetProt/(Loss)fortheperiod(beforeTax, 2 Exceptionaland/orextraordinaryitems) 1296.45 590.37 1244.68 1886.82 1745.09 4067.57 2347.45 1365.99 1244.68 3713.44 1745.09 4250.72 NetProt/(Loss)fortheperiodbeforetax 3 (afterExceptionaland/orextraordinaryitems) 1296.45 590.37 1244.8 1886.82 1745.09 4067.57 2347.45 1365.99 1244.68 3713.44 1745.09 4250.72 NetProt/(Loss)fortheperiodaftertax 4 (afterExceptionaland/orextraordinaryitems) 804.67 479.71 931.73 1284.38 1286.42 2780.82 1717.80 828.14 931.73 2545.94 1286.42 2908.81 TotalComprehensiveIncomefortheperiod 5 (ComprisingProtfortheperiod(aftertax) 808.13 477.98 931.73 1286.11 1286.42 2775.73 1721.42 826.25 931.73 2547.67 1286.42 2903.72 andotherComprehensiveIncome(aftertax) 10630.30 10630.30 5315.15 10630.30 5315.15 5315.15 10630.30 10630.30 5315.15 10630.30 5315.15 5315.15 6 Paid-upEquityShareCapital (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof (FaceValueof Rs.02/-each) Rs.02/-each) Rs.10/-each) Rs.02/-each) Rs.10/-each) Rs.10/-each) Rs.02/-each) Rs.02/-each) Rs.10/-each) Rs.02/-each) Rs.10/-each) Rs.10/-each) Reserves(ExcludingRevaluationReserve)asshown 7 intheAuditedBalanceSheetofthepreviousyear - - - - - - - - - - - - EarningsPerShare(FaceValue 8 Rs.10perShare)BasicDiluted 0.15 0.09 0.18 0.24 0.24 0.59 0.32 0.16 0.18 0.48 0.24 0.61 Notes:1.TheaboveisanextractofthedetailedformatofStandaloneandConsolidatedUnauditedFinancialResultsforthequarterendedSeptember30,2026filedwiththestockexchangeunder Regulation33and52oftheSEBI(ListingObligationsandDisclosureRequirements)Regulations,2015.ThefullformatofStandaloneandConsolidatedUnauditedFinancialResultsforthequarterended September30,2026areavailableontheStockExchangeWebsiteofBSE(www.bseindia.com),NSE(www.nseindia.com),andcompany’swebsite [Showing first 8,000 characters — download PDF for full document]